Anti—factor Xa Assay: An Effective Method to Determine the Appropriate Dose of Heparin in Pregnant Women

Laurent P. , Dussarat GV , Bonal J. , et al. Low-molecular weight heparins: a guide to their optimum use in pregnancy. Drugs. 2002;62:463-477.

Ginsberg JS , Greer I. , Hirsh J. Use of antithrombotic agents during pregnancy. Chest. 2001;119:122S-131S.

Forestier F. , Daffos F. , Rainaut M. , et al. Low-molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy [abstract] . Thromb Haemost. 1987;57:234.

Crowther MA , Spitzer K. , Julian J. , et al. Pharmacokinetic profile of a low-molecular weight (Reviparin) in pregnant patients: a prospective cohort study. Thromb Res. 2000; 98:133-138.

Yin ET , Wessler S. , Butler JV Plasma heparin: a unique, practical, submicrogram-sensitive assay. J Lab Clin Med. 1973;81:298-397.